Search research articles
Contact Us
Filters
Showing results (61-70 of 171) with videos related to
Page
of 18
Sort By:
Annals of Internal Medicine
|
April 1, 1981
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon
M B Kahaleh, I Osborn, E C LeRoy
Annals of Internal Medicine
|
May 1, 1982
Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma
M B Kahaleh, I Osborn, E C Leroy
The Journal of Clinical Investigation
|
September 1, 1984
Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin I2 production, adenine nucleotide release, and responses to vasoactive agents
E C LeRoy, A Ager, J L Gordon
Clinical and Experimental Rheumatology
|
March 1, 1991
The pathogenesis of scleroderma (systemic sclerosis, SSc)
E C LeRoy, M Trojanowska, E A Smith
The Journal of Rheumatology
|
April 1, 1989
Transitions in generalized scleroderma
R Lomeo, M B Kahaleh, E C Leroy
Inflammation
|
March 1, 1983
Neutrophil response to LIF: lack of glucocorticoid effect despite enhanced chemokinesis
D P Lurie, F DeLustro, E C LeRoy
Cell
|
May 8, 1987
TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression
K Takehara, E C LeRoy, G R Grotendorst
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1982
Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors
E C LeRoy, S Mercurio, G K Sherer
Oncogene
|
October 1, 1988
Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts
M Trojanowska, L T Wu, E C LeRoy
The Medical Clinics of North America
|
January 1, 1997
Scleroderma and related conditions
H Mitchell, M B Bolster, E C LeRoy
Page
of 18
Search research articles
Search
Showing results (61-70 of 171) with videos related to
Sort By:
Page
of 18
Annals of Internal Medicine
|
April 1, 1981
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon
M B Kahaleh, I Osborn, E C LeRoy
Annals of Internal Medicine
|
May 1, 1982
Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma
M B Kahaleh, I Osborn, E C Leroy
The Journal of Clinical Investigation
|
September 1, 1984
Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin I2 production, adenine nucleotide release, and responses to vasoactive agents
E C LeRoy, A Ager, J L Gordon
Clinical and Experimental Rheumatology
|
March 1, 1991
The pathogenesis of scleroderma (systemic sclerosis, SSc)
E C LeRoy, M Trojanowska, E A Smith
The Journal of Rheumatology
|
April 1, 1989
Transitions in generalized scleroderma
R Lomeo, M B Kahaleh, E C Leroy
Inflammation
|
March 1, 1983
Neutrophil response to LIF: lack of glucocorticoid effect despite enhanced chemokinesis
D P Lurie, F DeLustro, E C LeRoy
Cell
|
May 8, 1987
TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression
K Takehara, E C LeRoy, G R Grotendorst
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1982
Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors
E C LeRoy, S Mercurio, G K Sherer
Oncogene
|
October 1, 1988
Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts
M Trojanowska, L T Wu, E C LeRoy
The Medical Clinics of North America
|
January 1, 1997
Scleroderma and related conditions
H Mitchell, M B Bolster, E C LeRoy
Page
of 18